What We Monitor for Medical Device Manufacturers
510(k) submission requirements
PMA pathway updates
De Novo classification changes
QSR / QMSR modernization
UDI enforcement signals
Cybersecurity guidance evolution
Post-market surveillance (MDR/MAUDE)
Inspection focus areas
Recall trend analysis
Decisions This Intelligence Affects
Regulatory Affairs
- • Pathway selection (510(k)/PMA/De Novo)
- • Predicate device strategy
- • Pre-submission meeting timing
- • Special 510(k) eligibility
Quality & Compliance
- • QMS alignment with QMSR
- • Design control documentation
- • Supplier qualification updates
- • CAPA process improvements
Legal & Risk
- • Warning letter trend awareness
- • Recall risk assessment
- • Cybersecurity liability exposure
- • Post-market reporting obligations
Executive Leadership
- • Product launch timeline confidence
- • Portfolio regulatory risk
- • Competitive intelligence
- • M&A due diligence
How Device Teams Use This Intelligence
Prepare for QMSR Transition
Understand ISO 13485 alignment requirements before enforcement begins
Optimize 510(k) Strategy
Track substantial equivalence interpretation shifts
Accelerate Clearance Decisions
Pre-interpreted guidance reduces internal analysis time
Monitor Cybersecurity Expectations
Stay ahead of evolving software security requirements
Brief Leadership on Inspection Trends
Cite intelligence in board and management discussions
Document Regulatory Rationale
Support design and compliance decisions with intelligence